These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Canadian Clobazam Cooperative Group. Epilepsia; 1991; 32(3):407-16. PubMed ID: 2044502 [Abstract] [Full Text] [Related]
31. Impact of CYP2C19 Phenotypes on Clinical Efficacy of Stiripentol in Japanese Patients With Dravet Syndrome. Yamamoto Y, Takahashi Y, Ikeda H, Imai K, Kagawa Y, Inoue Y. Ther Drug Monit; 2020 Apr; 42(2):302-308. PubMed ID: 31318844 [Abstract] [Full Text] [Related]
39. Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy center. Montenegro MA, Arif H, Nahm EA, Resor SR, Hirsch LJ. Clin Neuropharmacol; 2008 Jan; 31(6):333-8. PubMed ID: 19050410 [Abstract] [Full Text] [Related]